Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hampartsoum B Barsoumian

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Plos One|April 7, 2016
4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell SuppressionHampartsoum B Barsoumian, Esma S Yolcu, Haval Shirwan
Seminars in Radiation Oncology|June 16, 2024
Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?Vivek Verma, Hampartsoum B Barsoumian, James W Welsh
Therapeutic Advances in Medical Oncology|November 16, 2020
Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshellFadi E El Rami, Hampartsoum B Barsoumian, Gebran W Khneizer
International Journal of Radiation Oncology, Biology, Physics|February 10, 2020
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 TrialsDawei Chen, Vivek Verma, Roshal R Patel, et al.
Vaccines|February 2, 2018
Radiation and Anti-Cancer Vaccines: A Winning CombinationAlexandra Cadena, Taylor R Cushman, Clark Anderson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2020
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapyDawei Chen, Roshal R Patel, Vivek Verma, et al.
Research Square|February 24, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Advances in Radiation Oncology|January 12, 2023
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and RetentionHampartsoum B Barsoumian, Rahul A Sheth, Rishab Ramapriyan, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Frontiers in Oncology|January 23, 2024
Corrigendum: Lipid metabolism in tumor immunology and immunotherapyLisa K Duong, Halil Ibrahim Corbali, Thomas S Riad, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Plos One|April 7, 2016
4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell SuppressionHampartsoum B Barsoumian, Esma S Yolcu, Haval Shirwan
Seminars in Radiation Oncology|June 16, 2024
Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?Vivek Verma, Hampartsoum B Barsoumian, James W Welsh
Therapeutic Advances in Medical Oncology|November 16, 2020
Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshellFadi E El Rami, Hampartsoum B Barsoumian, Gebran W Khneizer
International Journal of Radiation Oncology, Biology, Physics|February 10, 2020
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 TrialsDawei Chen, Vivek Verma, Roshal R Patel, et al.
Vaccines|February 2, 2018
Radiation and Anti-Cancer Vaccines: A Winning CombinationAlexandra Cadena, Taylor R Cushman, Clark Anderson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2020
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapyDawei Chen, Roshal R Patel, Vivek Verma, et al.
Research Square|February 24, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Advances in Radiation Oncology|January 12, 2023
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and RetentionHampartsoum B Barsoumian, Rahul A Sheth, Rishab Ramapriyan, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.
Frontiers in Oncology|January 23, 2024
Corrigendum: Lipid metabolism in tumor immunology and immunotherapyLisa K Duong, Halil Ibrahim Corbali, Thomas S Riad, et al.
Pageof 5